Fruhbeis Todd Michael

Director Fruhbeis bought 2,400 shares ($24,047) across 6 transactions Mar 25-27 at $9.76–$10.17, raising holdings 22.5%; cluster buy signal amid unprofitable financials.

Fruhbeis Todd Michael, a Director, executed 6 separate open-market purchases totaling 2,400 shares for $24,047.00 between March 25–27, 2026, at prices ranging from $9.76 to $10.17 (blended average $10.02), increasing his stake by 22.5% to 13,073 shares. This filing appears as part of a cluster pattern, with 2 other insiders also buying within the past 14 days, suggesting coordinated or coincidental confidence. Structurally, the split across three days at varying prices—rather than a single lump purchase—may reflect phased entry or order-execution constraints. The company is currently unprofitable (net income −$1.8M in latest quarter) despite strong annual revenue growth of +22.9%, creating a risk-reward asymmetry: insiders may be perceiving a valuation inflection point post-losses, or simply accumulating at perceived levels. His prior buy at this ticker on 2025-09-16 returned +7.8% over 90 days, and his cross-ticker track record shows 100.00% 90-day win rate on buys (avg +4.7%), suggesting a pattern of well-timed accumulation, though historical performance does not guarantee future outcomes.

Director Fruhbeis bought 250 STRR shares at $10.20; insider cluster pattern emerges as 2 others also bought within 14 days

Fruhbeis Todd Michael (Director) purchased 250 shares at $10.20, bringing holdings to 9,872 shares (+2.6% increase). The transaction occurs within a cluster pattern: 2 other insiders also bought within the past 14 days. This synchronous buying by multiple insiders, combined with the stock's recent sharp price movement (30-day change +457.6%, 90-day change +481.4%), suggests internal stakeholders are actively accumulating at current levels. However, STRR faces material headwinds: the company posted negative net income of $-688,000.00 in the latest quarter, annual revenue declined 13.2% year-over-year, and the stock still trades near its 52-week high of $11.57 despite unprofitability. The confluence of multi-insider buying activity against a backdrop of deteriorating financial fundamentals warrants scrutiny of whether insiders possess non-public information or are simply reacting to the recent appreciation.

Director Fruhbeis buys 751 HSON shares at $9.58; 2nd purchase in 5 days as part of 2-insider cluster, amid -13.2% revenue decline and unprofitability.

Director Todd Michael Fruhbeis purchased 751 shares at $9.58 on 2025-09-02, his second open-market buy in 5 days (prior purchase 2025-08-28) and part of a cluster of 2 other insiders also buying within the past 14 days. The transaction increased his holdings by 40.4% from 1,859 to 2,610 shares. However, Hudson Global's fundamentals present headwinds: revenue declined 13.2% year-over-year to $35.5M (latest quarter), the company posted net income of -$688.0K, and was unprofitable over its most recent full fiscal year. The stock is currently trading at $9.88, down 45.7% from its 52-week high of $18.21. The rapid consecutive purchases by Fruhbeis paired with simultaneous buying by other insiders warrant examination of whether this reflects information asymmetry or coordinated response to recent market weakness (up 10.4% over 90 days), though the company's profitability challenges remain unresolved.

Hudson Global Director Fruhbeis buys 1,100 shares at $9.58; +144.9% increase to 1,859 share holdings; cluster buy pattern active.

Fruhbeis Todd Michael, a Director at Hudson Global, purchased 1,100 shares at $9.58 on 2025-08-28, increasing his holdings by 144.9% from 759 to 1,859 shares. This represents a material expansion of his position in the company, coinciding with a cluster buy pattern where 2 other insiders also bought within the past 14 days. However, the company fundamentals present a significant headwind: Hudson Global posted negative net income of $-688,000.00 in the latest quarter, experienced annual revenue decline of -13.2%, and operates a $26.2M market cap business. The stock is currently down 47.7% from its 52-week high of $18.21, trading at $9.52—near the purchase price. The combination of increased insider accumulation alongside deteriorating earnings and substantial unrealized losses from the 52-week peak merits closer examination of management's conviction relative to underlying business performance.